HF
HURA

HRT Financial’s TuHURA Biosciences HURA Stock Holding History

HRT Financial’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,332
Closed -$8K – 3277
2024
Q1 		$8K Buy
+2,332
New +$9.37K ﹤0.01% 2088
2022
Q4 		– Sell
-22
Closed -$4K – 3299
2022
Q3 		$4K Buy
+22
New +$7.03K ﹤0.01% 2613

Other funds holding HURA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HRT Financial's HURA Position: Q2 2024 in Review

HRT Financial sold out of TuHURA Biosciences (HURA) in Q2 2024, closing a stake of 2,332 shares — an estimated $8K sold.

HRT Financial first reported a position in HURA in Q3 2022 and held it in 2 quarters. The position peaked at $8K in Q1 2024. 17 funds tracked by Wall St. Rank hold HURA as of Q2 2024.

  • HRT Financial reported no remaining TuHURA Biosciences position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 2,332 TuHURA Biosciences shares in Q2 2024, an estimated $8K.
  • HRT Financial first reported a position in TuHURA Biosciences in Q3 2022 and held it in 2 quarters.
  • HRT Financial's TuHURA Biosciences position peaked at $8K in Q1 2024.
  • 17 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.